Ex­clu­sive: En­gi­neered B cell ther­a­py start­up Walk­ing Fish shuts down

Walk­ing Fish Ther­a­peu­tics, a biotech start­up that at­tempt­ed to cre­ate en­gi­neered B cell ther­a­pies, has shut­tered, founder Rusty Williams con­firmed to End­points News.

The South San Fran­cis­co biotech emerged in 2021 on the idea that sci­en­tists could turn B cells, which func­tion like a fac­to­ry that pro­duces large amounts of pro­teins and an­ti­bod­ies, in­to ther­a­peu­tics. It had 35 em­ploy­ees at its peak.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER